Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Brighter AB (Publ) ("Brighter") announces today that its subsidiary Pink Nectarine Health AB ("Nectarine Health" or "The Company'') has had its application for corporate restructuring (Sw. "företagsrekonstruktion") approved by the Stockholm district court.
The Stockholm district court accepted Nectarine Health's proposal to have lawyer Lars Söderqvist (Wesslau Söderqvist Advokatbyrå i Stockholm KB) appointed as restructuring trustee. Lars Söderqvist has worked with formal and informal corporate restructuring and other related advisory work since 1982 and has extensive experience in restructuring large-scale operations.
The purpose of the corporate restructuring is to give the Company time to complete discussions with potential commercial partners in the US to establish a structure for the commercialization in the USA. It is also intended to continue ongoing negotiations for a long-term financial solution and conclude these as well as implement the necessary operational changes.
"The approved corporate restructuring is good and important news. Now Nectarine Health is given the opportunity to continue ongoing discussions and thus the opportunity to realize the potential that exists in the company," says Christer Trägårdh, Chairman of the board of Nectarine Health and Brighter.
The meeting of creditors will be held on October 17 2022 at 15:30 PM in the premises of Stockholms tiingsrätt.
For more information, please contact:
Investor Relations
IR@brighter.se
Certified Adviser
Brighter's Certified Adviser is Mangold Fondkommission AB, www.mangold.se
About Brighter
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers - aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter's quality management system is ISO13485 certified. In 2019 the Company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.
For more information, please visit our website at www.brighter.se.
This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on 30 September at 09:06 CEST.